Tumor necrosis factor ligand-receptor system can predict treatment outcome in lymphoma patients.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

A prospective study was performed to assess plasma measurement of tumor necrosis factor (TNF), lymphotoxin alpha (LTalpha), and their soluble receptors (p55 and p75) for prognostic risk assignment in patients with malignant lymphomas.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): J Clin Oncol

Title: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Publisher: American Society of Clinical Oncology (ASCO)

ISSN: 0732-183X

ISSN (Print): 0732-183X

Publication date (Electronic): Feb 1997

Volume: 15

Issue: 2

Affiliations

[1 ] Service d'Hématologie and Laboratoire d'Immunologie, Centre Hospitalier Lyon-Sud, Lyon, France.

Article

DOI: 10.1200/JCO.1997.15.2.499

PubMed ID: 9053471

SO-VID: 3e6163b4-fed6-4bd6-a849-ca5fe22fd3f7

History

Data availability:

Comments

Comment on this article

scite_

Cited by 16

See all cited by

- Version 1